As depicted in Figure 1(a) and Table S1, the DHX37 expression was elevated in breast (1.5, P = 5.45e − 9), colorectal (3.526, P = 5.14e − 5), gastric (3.866, P = 2.24e − 9), kidney (3.023, P = 5.81e − 4), and lung cancers (2.357, P = 6.95e − 5) as well as lymphoma (2.032, P = 3.03e − 7), whereas DHX37 was only observed significantly reduced in the sarcoma dataset (-1.632, P = 5.15e − 5). Here, DHX37 is linked to lymphoma.